Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions

Naoaki Fujii, Jose J. Haresco, Kathleen A P Novak, Robert M. Gage, Nicoletta Pedemonte, David Stokoe, Irwin D. Kuntz, R. Kiplin Guy

Research output: Contribution to journalArticlepeer-review

Abstract

Novel small molecules were designed to specifically target the ligand-binding pocket of a PDZ domain. Iterative molecular docking and modeling allowed the design of an indole scaffold 10a as a reversible inhibitor of ligand binding. The 10a scaffold inhibited the interaction between MAGI-3 and PTEN and showed cellular activities that are consistent with the inhibition of NHERF-1 function.

Original languageEnglish
Pages (from-to)549-552
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number2
DOIs
Publication statusPublished - Jan 15 2007

Keywords

  • Drug design
  • Interaction
  • NHERF
  • PDZ domain
  • Protein-protein

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions'. Together they form a unique fingerprint.

Cite this